Pryidostigmine Bromide
- Product NDC
- 16571-833
- 11-digit product format
- 165710833
- Labeler code
- 16571
- Product ID
- 16571-833_b46177b2-68dc-4958-a4ec-d4bd6d887456
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pyridostigmine Bromide
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Rising Pharma Holdings, Inc.
- Application
- ANDA208797
- Marketing category
- ANDA
- Marketing start
- 2022-09-15
- Substance
- PYRIDOSTIGMINE BROMIDE
- Active strength
- 60 mg/5mL
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pryidostigmine Bromide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PYRIDOSTIGMINE BROMIDE | 60 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | KVI301NA53 |
| Rxcui | 903843 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 16571-833-16 | Pryidostigmine Bromide | 473 mL in 1 BOTTLE, PLASTIC | SOLUTION | 473 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 16571-833 | PRYIDOSTIGMINE BROMIDE (PYRIDOSTIGMINE BROMIDE) SOLUTION [RISING PHARMA HOLDINGS, INC.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20220915_beda905e-005a-439d-ac74-92db4e269780.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16571-833-16 | 16571083316 | 473 mL in 1 BOTTLE, PLASTIC (16571-833-16) | 473 ml | 2022-09-15 | 0000-00-00 | No | No | Current |